JP2001521902A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521902A5
JP2001521902A5 JP2000518676A JP2000518676A JP2001521902A5 JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5 JP 2000518676 A JP2000518676 A JP 2000518676A JP 2000518676 A JP2000518676 A JP 2000518676A JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
crosslinking agent
polymer
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000518676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001521902A (ja
JP4452402B2 (ja
Filing date
Publication date
Priority claimed from US08/964,956 external-priority patent/US5985938A/en
Application filed filed Critical
Publication of JP2001521902A publication Critical patent/JP2001521902A/ja
Publication of JP2001521902A5 publication Critical patent/JP2001521902A5/ja
Application granted granted Critical
Publication of JP4452402B2 publication Critical patent/JP4452402B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000518676A 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用 Expired - Lifetime JP4452402B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/964,956 US5985938A (en) 1997-11-05 1997-11-05 Method for reducing oxalate
US08/964,956 1997-11-05
PCT/US1998/022606 WO1999022744A1 (en) 1997-11-05 1998-10-26 Use of aliphatic polyamines for reducing oxalate

Publications (3)

Publication Number Publication Date
JP2001521902A JP2001521902A (ja) 2001-11-13
JP2001521902A5 true JP2001521902A5 (cg-RX-API-DMAC10.html) 2006-01-05
JP4452402B2 JP4452402B2 (ja) 2010-04-21

Family

ID=25509224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000518676A Expired - Lifetime JP4452402B2 (ja) 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用

Country Status (10)

Country Link
US (3) US5985938A (cg-RX-API-DMAC10.html)
EP (2) EP1044008B1 (cg-RX-API-DMAC10.html)
JP (1) JP4452402B2 (cg-RX-API-DMAC10.html)
AR (1) AR016001A1 (cg-RX-API-DMAC10.html)
AU (1) AU1364799A (cg-RX-API-DMAC10.html)
CA (1) CA2349620C (cg-RX-API-DMAC10.html)
DE (1) DE69833134T2 (cg-RX-API-DMAC10.html)
TW (1) TW585772B (cg-RX-API-DMAC10.html)
WO (1) WO1999022744A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA989671B (cg-RX-API-DMAC10.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) * 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
WO2002085377A1 (en) * 2001-04-18 2002-10-31 Genzyme Corporation Method for lowering serum glucose
BR0209020A (pt) * 2001-04-18 2004-08-10 Genzyme Corp Composição farmacêutica de polialilamina
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
EP1379259A1 (en) 2001-04-18 2004-01-14 Genzyme Corporation Methods of treating syndrome x with aliphatic polyamines
EP1923064B1 (en) 2001-04-18 2017-06-28 Genzyme Corporation Use of amine polymer for lowering serum glucose
CA2444347A1 (en) * 2001-04-18 2002-10-31 Genzyme Corporation Method for treating gout and binding uric acid
JP4515030B2 (ja) 2001-04-23 2010-07-28 アノーメッド インコーポレイティド 腎臓結石疾患の予防のための希土類化合物の使用
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
JP2005537037A (ja) * 2001-10-05 2005-12-08 イクシオン・バイオテクノロジー・インコーポレーテッド 流体の蓚酸塩濃度を減少させる物質および方法
US6600011B2 (en) * 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
IL161185A0 (en) * 2001-10-09 2004-08-31 Genzyme Corp A method of purifying and drying a polymer hydrogel
US7220406B2 (en) * 2002-10-22 2007-05-22 Genzyme Corporation Method for promoting bone formation
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
DE602005019992D1 (de) 2004-03-30 2010-04-29 Relypsa Inc Kaliumbindende polymere und ihre verwendungen
EP1755655A4 (en) * 2004-05-07 2011-03-30 Oxthera Inc METHOD AND COMPOSITIONS FOR REDUCING OXALATE CONCENTRATIONS
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
WO2006072054A1 (en) * 2004-12-30 2006-07-06 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
CN103027896B (zh) * 2005-09-15 2016-01-20 基酶有限公司 胺聚合物的小袋制剂
CA2626734A1 (en) * 2005-11-08 2007-05-18 Genzyme Corporation Magnesium-containing polymers for the treatment of hyperphosphatemia
SI1962873T1 (sl) * 2005-12-14 2013-10-30 Oxthera Intellectual Property Ab Farmacevtski sestavki, ki vsebujejo bakterijo za zmanjšanje oksalata
EP2366402A1 (en) 2005-12-16 2011-09-21 OxThera, Inc., Compositions and methods for oxalate reduction
JP2009536246A (ja) * 2006-05-05 2009-10-08 ゲンズイメ コーポレーション ホスフェート捕捉剤としてのアミン縮合重合体
US20100135950A1 (en) * 2006-07-05 2010-06-03 Genzyme Corporation Iron(II)-Containing Treatments for Hyperphosphatemia
US9375499B2 (en) * 2006-07-14 2016-06-28 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
US20100124542A1 (en) * 2006-07-18 2010-05-20 Genzyme Corporation Amine dendrimers
PT2046373E (pt) * 2006-08-02 2013-05-06 Althea Technologies Inc Oxalato descarboxilase cristalizada e métodos de utilização
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
EP2076286B1 (en) * 2006-10-25 2016-03-09 Wisconsin Alumni Research Foundation Methods of reducing phosphate absorption using an anti-npt2b antibody
CA2667613A1 (en) * 2006-10-26 2008-06-05 Wisconsin Alumni Research Foundation Methods for reducing phosphate absorption
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
US20100129309A1 (en) * 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
US20100196305A1 (en) * 2007-03-08 2010-08-05 Dhal Pradeep K Sulfone polymer compositions
EP2139461A2 (en) * 2007-03-20 2010-01-06 Recepticon Aps Amino derivatives to prevent nephrotoxicity and cancer
EP2152277A1 (en) * 2007-04-27 2010-02-17 Genzyme Corporation Amido-amine dendrimer compositions
JP2011506449A (ja) * 2007-12-14 2011-03-03 ジェンザイム コーポレーション コーティング医薬組成物
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
WO2010123039A1 (ja) * 2009-04-21 2010-10-28 株式会社医学生物学研究所 生物学的材料の不動化を行うための組成物
WO2014113648A1 (en) 2013-01-18 2014-07-24 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
CA2906501A1 (en) * 2013-03-15 2014-09-25 Genzyme Corporation Sequestrants of advanced glycation end product (age) precursors
CA2913476A1 (en) 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
US10435528B2 (en) 2013-09-17 2019-10-08 Aquanano Llc High-capacity anion exchange materials
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
EP3277099B9 (en) 2015-04-02 2024-05-29 Oxidien Pharmaceuticals, Llc High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
GB201718803D0 (en) * 2017-11-14 2017-12-27 Phoenix Molecular Pte Ltd Method for isolation of nucleic acids
US11993670B2 (en) 2018-06-06 2024-05-28 The Board Of Trustees Of The University Of Illinois Zwitterionic biocompatible polymers, methods, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198396A (en) * 1974-07-03 1980-04-15 Warren-Teed Laboratories, Inc. Dissolution of gallstones
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS60202869A (ja) * 1984-03-26 1985-10-14 Ajinomoto Co Inc 大環状ポリアミン誘導体及びその用途
DE3727082A1 (de) * 1987-08-14 1989-02-23 Goedecke Ag Pharmazeutische zubereitungen zur behandlung der urolithiasis
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
WO1998017707A1 (en) * 1996-10-23 1998-04-30 The Dow Chemical Company Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate

Similar Documents

Publication Publication Date Title
JP2001521890A5 (cg-RX-API-DMAC10.html)
JP2004535384A5 (cg-RX-API-DMAC10.html)
JP2004528332A5 (cg-RX-API-DMAC10.html)
JP2007506838A5 (cg-RX-API-DMAC10.html)
JP2021536523A5 (cg-RX-API-DMAC10.html)
CA2444046A1 (en) Use of colesevelam in reducing serum glucose
JP2002541278A5 (cg-RX-API-DMAC10.html)
EP1645278A3 (en) Use of aliphatic polyamines for reducing oxalate
JP2004520473A5 (cg-RX-API-DMAC10.html)
EP0391413A3 (en) Filled polymeric blend
DE69825619D1 (de) Strikt alternierende poly(alkylenoxid)copolymere
EP0838487A3 (en) Polyether copolymer and polymer solid electrolyte
JP2001509529A5 (cg-RX-API-DMAC10.html)
JPH11295933A5 (cg-RX-API-DMAC10.html)
JP2013513135A5 (cg-RX-API-DMAC10.html)
RU96124822A (ru) Поперечно-сшитые полимеры для удаления из организма человека солей желчных кислот
ATE288956T1 (de) Verwendung eines amphoteren polymeres zur behandlung ausgewählter harter oberflächen
ES2138231T3 (es) Polimeros radio-opacos y metodos para su preparacion.
CA2481365A1 (en) Occlusive composition comprising a poly (2-cyanoacrylate) monomer
JP2003518152A5 (cg-RX-API-DMAC10.html)
JP2004244633A5 (cg-RX-API-DMAC10.html)
EP1138730A3 (en) Aqueous polymer emulsions
ES2194952T3 (es) Composicion polimerica modificada con goma.
JP2001525340A5 (cg-RX-API-DMAC10.html)
JP2006503143A5 (cg-RX-API-DMAC10.html)